Enflame Triples in Shanghai Debut on AI Chip Demand

Shanghai Enflame Technology Co. opened at 410 yuan, more than double its 142.18 yuan offer price, and traded as high as 475 yuan on its debut on the STAR Market. According to data reported by Reuters, the stock’s market capitalization reached approximately 185 billion yuan, representing a value three times higher than the 61.2 billion yuan valuation implied by the IPO pricing. This immediate revaluation reflects aggressive investor positioning ahead of the company’s expanded production capabilities.

The company raised 6.12 billion yuan, or roughly $912 million, by issuing 43.04 million new shares, which constituted 10% of its enlarged share capital. At the start of trading, only 17.9 million shares, or 4.16% of the post-IPO total, were freely tradable. This limited free float, combined with subscription demand for the online portion that exceeded available shares by over 6,000 times, created a supply-constrained market that amplified price volatility during the first session.

Subscription demand exceeds supply limits

Investor appetite for Enflame shares was evident in the pre-market subscription data. Reuters reported that orders for the online portion were placed at 6,109 times the available shares, while Bloomberg calculations indicated the retail portion was subscribed at 4,073 times after the company adjusted share allocations. This level of demand indicates that investors are prioritizing access to domestic AI hardware over immediate financial metrics, viewing the stock as a proxy for China’s broader push to reduce reliance on foreign computing technology.

Strategic role in domestic chip supply

Enflame is the final member of the so-called 'four little GPU dragons' to list publicly in China. It follows Moore Threads, which raised 8 billion yuan and closed its debut up 425% in December 2025, and MetaX, which raised 4.2 billion yuan and finished its first session up 693%. Biren Technology took a different path, listing in Hong Kong in January 2026. Enflame’s entry completes the public market presence of these key domestic competitors, intensifying the competitive landscape for AI accelerators in the region.

Founded in 2018 by former AMD engineers, Enflame manufactures chips, accelerator cards, and systems for data center AI workloads. The company stated it will use IPO proceeds to develop fifth and sixth-generation AI chips, associated software, and large-scale computing systems. While Enflame currently holds an estimated 1.7% share of China’s AI accelerator market, compared to Nvidia’s 55% share in 2025 according to SWS Research, its public listing positions it to capture a larger portion of the market as Beijing mandates the use of domestic hardware in government and enterprise projects.

Valuation reflects policy-driven market shift

The market pricing of Enflame shares is driven less by current revenue and more by the strategic necessity of domestic substitution. US export controls have restricted access to Nvidia’s most advanced chips, prompting Chinese buyers to seek local alternatives. Enflame’s backers, including Tencent, are betting on this shift, as the company’s products are increasingly integrated into state-supported AI infrastructure. The high initial valuation suggests that investors are paying for the potential market share Enflame can gain through policy support rather than its existing financial performance.

As the domestic AI chip sector matures, Enflame’s ability to scale production and maintain competitive pricing against both legacy foreign suppliers and newer domestic rivals will determine its long-term viability. The company’s focus on next-generation hardware and software ecosystems aims to address the performance gap that has historically kept domestic chips out of high-end data centers. With the public market now providing significant capital, Enflame is positioned to accelerate its R&D cycle and expand its footprint in China’s growing AI infrastructure market.